Abstract
Objective. Racial disparities in breast cancer outcomes are well documented: African-American (AA) women have markedly poorer survival than do European-American (EA) women. A growing literature suggests that AA women have, on average, tumors of more aggressive histopathology, even if discovered early. We investigated this in our South Carolina population.
Methods. Tumor registry data for 1687 AA and EA women with breast cancers newly diagnosed during 2000–2002 at the two Palmetto Health hospitals in Columbia, SC, were reviewed.
Results. Corresponding to our regional population, 31% of cancers were in AA women. In both racial groups, 19% were in situ. Among women with invasive cancers, AA women had significantly earlier age at diagnosis than did EA women. Fewer AA women had lobular carcinoma (p =0.001) or Her-2 over-expressing disease (7 versus 19%, p =0.001). Significantly more AA women had high-grade cancer, larger tumors, axillary metastases and ER negative/PR negative tumors. After controlling for T-stage, AA women were significantly more likely to have high-grade and/or ER negative disease. Detection of invasive cancers by screening mammogram was less frequent in AA women (40 versus 53%, p< 0.000), and in small ER negative cancers.
Conclusions. At diagnosis, breast cancers in AA women tend to have the hallmarks of more aggressive and less treatable disease, even in small tumors, a pattern resembling that of breast cancers in younger EA women. Whatever the causes, these observations suggest breast cancer is biologically different in AA women. This may contribute substantially to the poorer outcomes in African-American women.
Similar content being viewed by others
References
Jemal A, Murray T, Thun M:Cancer Statistics, 2002. CA Cancer J Clin 52:23–47, 2002
SEER Cancer Statistics Review, 1975–2000. National Cancer Institute, Bethesda, MD, 2003
Chu KC, Tarone RE, Brawley OW:Breast cancer trends of black women compared with white women. Arch Fam Med 8:521–528, 1999
Moorman P, Jones B, Millikan R, Hall I, Newman B:Race, anthropometric factors, and stage at diagnosis of breast cancer. Am J Epidemiol 153:284–291,2001
Young H, Ries LG, Pollack ES:Cancer patient survival among ethnic groups in the United States. J Natl Cancer Inst 73:341–352, 1984
Joslyn SA, West MM:Racial differences in breast carci-noma survival. Cancer 88:114–123, 2000
Jacobellis J, Cutter G:Mammography screening and differences in stage of disease by race/ethnicity. Am J Public Health 92:1144–1150, 2002
Joslyn SA:Racial differences in treatment and survival from early-stage breast cancer. Cancer 95:1759–1766, 2002
Newman LA, Mason J, Cote D, Vin Y, Carolin K, Bouwman D, Colditz GA:African-American ethnicity, socioeconomic status, and breast cancer survival. Cancer 94:2844–2854, 2002
Middleton LP, Chen V, Perkins GH, Pinn V, Page D: Histopathology of Breast Cancer among African-American women. Cancer 97:253–257, 2003
Trock BJ:Breast cancer in African American women: epidemiology and tumor biology. Breast Cancer Res Treat 40:11–24, 1996
Aziz H, Hussain F, Sohn C, Mediavillo R, Saitta A, Hussain A, Brands M, Homel P, Rotman M:Early onset of breast carcinoma in African American women with poor prognostic factors. Am J Clin Oncol 22:436–440, 1999
Butler WM, Cunningham J:Ethnic differences in breast cancer characteristics. Breast Cancer Online 4:2001
Chu KC, Anderson WF, Fritz A, Ries LA, Brawley OW: Frequency distributions of breast cancer characteristics classi ed by estrogen receptor and progesterone receptor status for eight racial/ethnic groups. Cancer 92:37–45, 2001
Li CI, Malone KE, Daling JR:Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older. Cancer Epidemiol Biomarkers Prevent 11:601–607, 2002
Chu KC, Anderson WF:Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups. Breast Cancer Res Treat 74: 199–211, 2002
Furberg H, Millikan R, Dressler L, Newman B, Geradts J: Tumor characteristics in African American and white women. Breast Cancer Res Treat 68:33–43, 2001
Gordon NH:Socioeconomic factors and breast cancer in black and white Americans. Cancer Metastasis Rev 22:55–65, 2003
Sanders LC, Hardy WR, Ashford-Carroll TS, Bolick-Aldrich SW:South Carolina Cancer Facts and Figures 2001–2002. South Carolina Central Cancer Registry, Office of Public Health Statistics and Information Services, South Carolina Department of Health and Environmental Con-trol, and the American Cancer Society, Southeast Division, 2001
Henson DE, Chu KC, Levine PH:Histologic grade, stage, and survival in breast carcinoma. Comparison of African American and Caucasian women. Cancer 98:907–917, 2003
Yoo KY, Tajima K, Miura S, Takeuchi T, Hirose K, Risch H, Dubrow R:Breast cancer risk factors according to combined estrogen and progesterone receptor status:a case-control analysis. Am J Epidemiol 146:307–314, 1997
Potter JD, Cerhan J, Sellers T, McGovern P, Drinkard C, Kushi LH, Folsom A:Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women 's Health Study:How many kinds of breast cancer are there? Cancer Epidemiol Biomarkers Prevent 4:319–326, 1995
Ademuyiwa FO, Olopade OI:Racial differences in genetic factors associated with breast cancer. Cancer Metastasis Rev 22:47–53, 2003
Quong J, Eppenberger-Castori S, Moore D III, Scott GK, Birrer MJ, Kueng W, Eppenberger U, Benz CC:Age-dependent changes in breast cancer hormone receptors and oxidant stress markers. Breast Cancer Res Treat 76:221–236, 2002
Bernstein L, Teal CR, Joslyn S, Wilson J:Ethnicity-related variation in breast cancer risk factors. Cancer 97(1 Suppl): 222–229, 2003
Li CI, Malone KE, Porter PL, Weiss NS, Tang MT, Daling JR:Reproductive and anthropometric factors in relation to the risk of lobular and ductal breast carcinoma among women 65–79 years of age. Int J Cancer 107:647–651,2003
Cotterchio M, Kreiger N, Theis B, Sloan M, Bahl S: Hormonal factors and the risk of breast cancer according to estrogen-and progesterone-receptor subgroup. Cancer Epidemiol Biomarkers Prev 12:1053–1060, 2003
Polednak AP:Trends in incidence rates for obesity-associ-ated cancers in the US. Cancer Detect Prev 27:415–421, 2003
Colditz GA, Feskanich D, Chen WY, Hunter DJ, Willett WC:Physical activity and risk of breast cancer in pre-menopausal women. Br J Cancer 89:847–851, 2003
Carpenter CL, Ross RK, Paganini-Hill A, Bernstein L: Effect of family history, obesity and exercise on breast cancer risk among postmenopausal women. Int J Cancer 106:96–102, 2003
Zhou JR, Yu L, Mai Z, Blackburn GL:Combined inhibition of estrogen-dependent human breast carcinoma by soy and tea bioactive components in mice. Int J Cancer 108:8–14, 2004
Sellers TA, Vierkant RA, Cerhan JR, Gapstur SM, Vachon CM, Olsen JE, Pankratz VS, Kushi LH, Folsom AR: Interaction of dietary folate intake, alcohol, and risk of hormone receptor-de ned breast cancer in a prospective study of postmenopausal women. Cancer Epidemiol Bio-markers Prev 11:1104–1107, 2002
Cho E, Spiegelman D, Hunter DJ, Chen WY, Colditz GA, Willett WC:Premenopausal dietary carbohydrate, glycemic index, glycemic load, and ber in relation to risk of breast cancer. Cancer Epidemiol Biomarkers Prev 12:1153–1158, 2003
Jakovljevic J, Touillaud MS, Bondy ML, Singletary SE, Pillow PC, Chang S:Dietary intake of selected fatty acids, cholesterol and carotenoids and estrogen receptor status in premenopausal breast cancer patients. Breast Cancer Res Treat 75:5–14, 2002
Wang LQ:Mammalian phytoestrogens:enterodiol and enterolactone. J Chromatogr B Analyt Technol Biomed Life Sci 777:289–309, 2002
Miller BA, Hankey BF, Thomas TL:Impact of sociodemo-graphic factors, hormone receptor status, and tumor grade on ethnic differences in tumor stage and size for breast cancer in US women. Am J Epidemiol 155:534–545, 2002
Meenagh A, Williams S, Ross OA, Patterson C, Gorodezky C, Hammond M, Leheny WA, Middleton D:Frequency of cytokine polymorphisms in populations from Western Europe, Africa, Asia, the Middle East and South America. Human Immunol 63:1055–1061,2002
Iacopetta B, Grieu F, Joseph D:The-174 G/C gene polymorphism in interleukin-6 is associated with an aggres-sive breast cancer phenotype. Br J Cancer 90:419–422, 2004
Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P:The effect of novel polymor-phisms in the interleukin-6 (IL-6)gene on IL-6 transcription and plasma IL-6 levels,and in association with systematic-onset juvenile chronic arthritis. J Clin Invest 102:1369–1376, 1998
Basolo F, Fiore L, Fontanini G, Conaldi PG, Calvo S, Fancone V, Toniolo A:Expression of and response to interleukin 6 (IL6)in human mammary tumors. Cancer Res 53:3118–3122, 1996
DeMichele A, Martin A-M, Mick R, Gor P, Wray L, Klein-Cabral M, Athanasiadis G, Colligan T, Stadtmauer E, Weber B:Interleukin-6–174GC polymorphism is associated with improved outcome in high-risk breast cancer. Cancer Res 63:8051–8056, 2003
Hassan MI, Aschner Y, Manning CH, Xu J, Aschner JL: Racial differences in selected cytokine allelic and genotypic frequencies among healthy, pregnant women in North Carolina. Cytokine 21:10–16, 2003
Ameyaw MM, Tayeb M, Thornton N, Folayan G, Tariq M, Mobarek A, Evans DA, Ofori-Adjei D, McLead HL: Ethnic variation in the HER-2 codon 655 genetic polymor-phism previously associated with breast cancer. J Hum Genet 47:172–175, 2002
Jernstrom H, Chu W, Vesprini D, Tao Y, Majeed N, Deal C, Pollak M, Narod SA:Genetic factors related to racial variation in plasma levels of insulin-like growth factor-1: implications for premenopausal breast cancer risk. Mol Genet Metab 72:144–154, 2001
Chen VW, Correa P, Kurman RJ, Wu XC, Eley JW, Austin D, Muss H, Hunter CP, Redmond C, Sobhan M et al.: Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev 3:127–135, 1994
Tuamokumo NL, Haffy BG:Clinical outcome and cosmesis in African-American patients treated with conservative surgery and radiation therapy. Cancer J 9:313–320, 2003
Bissell MJ, Radisky DC, Rizki A, Weaver VM, Petersen OW:The organizing principle:microenvironmental influences in the normal and malignant breast. Differentiation 70:537–546, 2002
Mouridsen HT, Rose C, Brodie AH, Smith IE:Challenges in the endocrine management of breast cancer. Breast Aug: S2–S19, 2003
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Cunningham, J.E., Butler, W.M. Racial disparities in female breast cancer in South Carolina: clinical evidence for a biological basis. Breast Cancer Res Treat 88, 161–176 (2004). https://doi.org/10.1007/s10549-004-0592-9
Issue Date:
DOI: https://doi.org/10.1007/s10549-004-0592-9